February 2021
1. KANG X, Chen X, He Y, Guo D, et al
   Corrigendum to "DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication" [Virology 435 (2013) 385-394].
   Virology. 2021 Feb 8. pii: S0042-6822(21)00021.
   

   >> Share

   
   June 2020
2. LAFONTAINE E, Miller CM, Permaul N, Martin ET, et al
   Ribosomal protein RACK1 enhances translation of poliovirus and other viral IRESs.
   Virology. 2020;545:53-62.
   

   >> Share

   
   October 2019
3. FORBERG K, Rodgers MA, Dawson GJ, Sauleda S, et al
   Human pegivirus 2 exhibits minimal geographic and temporal genetic diversity.
   Virology. 2019;539:69-79.
   

   >> Share

   
   September 2019
4. MEJER N, Galli A, Ramirez S, Fahnoe U, et al
   Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent.
   Virology. 2019;540:132-140.
   

   >> Share

   
   July 2019
5. ZHANG Y, Zhao X, Zou J, Yuan Z, et al
   Dual role of the amphipathic helix of hepatitis C virus NS5A in the viral polyprotein cleavage and replicase assembly.
   Virology. 2019;535:283-296.
   

   >> Share

   
   
6. LU G, Ou J, Sun Y, Wu L, et al
   Natural recombination of equine hepacivirus subtype 1 within the NS5A and NS5B genes.
   Virology. 2019;533:93-98.
   

   >> Share

   
   February 2019
7. JALAL PJ, King BJ, Saeed A, Adedeji Y, et al
   Elevated serum activity of MBL and ficolin-2 as biomarkers for progression to hepatocellular carcinoma in chronic HCV infection.
   Virology. 2019;530:99-106.
   

   >> Share

   
   January 2019
8. SUZUKI R, Matsuda M, Shimoike T, Watashi K, et al
   Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase.
   Virology. 2019;529:226-233.
   

   >> Share

   
   August 2018
9. ZHANG H, Qiao L, Luo G
   Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis.
   Virology. 2018;524:1-9.
   

   >> Share

   
   
10. GALLEGO I, Gregori J, Soria ME, Garcia-Crespo C, et al
    Resistance of high fitness hepatitis C virus to lethal mutagenesis.
    Virology. 2018;523:100-109.
    

    >> Share

    
    July 2018
11. HUMES D, Ramirez S, Jensen TB, Li YP, et al
    Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
    Virology. 2018;522:177-192.
    

    >> Share

    
    May 2018
12. WU Q, Li Z, Liu Q
    An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN.
    Virology. 2018;520:94-102.
    

    >> Share

    
    April 2018
13. KRAPCHEV VB, Rychlowska M, Chmielewska A, Zimmer K, et al
    Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice.
    Virology. 2018;519:33-41.
    

    >> Share

    
    March 2018
14. LI J, Feng S, Liu X, Guo M, et al
    Identification of nucleotides in the 5'UTR and amino acids substitutions that are essential for the infectivity of 5'UTR-NS5A recombinant of hepatitis C virus genotype 1b (strain Con1).
    Virology. 2018;518:253-263.
    

    >> Share

    
    February 2018
15. HUANG K, Chen J, Xu R, Jiang X, et al
    Molecular evolution of hepatitis C virus in China: A nationwide study.
    Virology. 2018;516:210-218.
    

    >> Share

    
    December 2017
16. MANICKAM C, Martinot AJ, Jones RA, Varner V, et al
    Hepatic immunopathology during occult hepacivirus re-infection.
    Virology. 2017;512:48-55.
    

    >> Share

    
    November 2017
17. CAMUS G, Xu S, Han B, Lu J, et al
    Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
    Virology. 2017;514:134-141.
    

    >> Share

    
    
18. MESALAM AA, Desombere I, Farhoudi A, Van Houtte F, et al
    Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
    Virology. 2017;514:30-41.
    

    >> Share

    
    August 2017
19. WU Q, Li Z, Liu Q
    Treatment with PTEN-Long protein inhibits hepatitis C virus replication.
    Virology. 2017;511:1-8.
    

    >> Share

    
    April 2017
20. BIEGEL JM, Henderson E, Cox EM, Bonenfant G, et al
    Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA.
    Virology. 2017;507:231-241.
    

    >> Share

    
    
21. EYRE NS, Aloia AL, Joyce MA, Chulanetra M, et al
    Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment.
    Virology. 2017;507:20-31.
    

    >> Share

    
    
22. KHERA L, Paul C, Kaul R
    Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1.
    Virology. 2017;506:110-120.
    

    >> Share

    
    October 2016
23. MISHRA P, Dixit U, Pandey AK, Upadhyay A, et al
    Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.
    Virology. 2016;500:35-49.
    

    >> Share

    
    September 2016
24. MAC DONALD-OTTEVANGER MS, Vreden S, van der Helm JJ, van de Laar T, et al
    Prevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname.
    Virology. 2016;499:114-120.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share